ARTICLE | Company News
Hemosol submits Hemolink MAA
February 26, 2001 8:00 AM UTC
Hemosol (TSE:HML) submitted an MAA for European approval of its Hemolink crosslinked hemoglobin 10 percent solution to reduce use of donor red blood cells in coronary artery bypass graft ( CABG) surge...